RxDoctor Payments Data

Marissa Reit, PA

Physician Assistant · Summerfield, FLNPI 1437633070

Payments from drug & device makers

$1,959in general payments, 2019–2025

Across 90 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$375
  • AbbVie$213
  • Amgen$173
  • Organogenesis Inc.$148
  • Novo Nordisk$142
  • Amarin Pharma, Inc.$127
  • plus $781 from 13 others

What the payments were for

  • Food & beverage$1,959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,959 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$190,521
Medicare patients
571
Services billed
2,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$31,348
SynthroidLevothyroxine Sodium29$2,604
Gabapentin56$1,804
Levothyroxine Sodium132$1,614
Rosuvastatin Calcium82$1,607
Albuterol Sulfate HfaAlbuterol Sulfate45$1,019
Pantoprazole Sodium58$1,005
Bupropion XlBupropion Hcl25$767
Atorvastatin Calcium58$681
Losartan Potassium53$621
Omeprazole38$604
Venlafaxine Hcl ErVenlafaxine Hcl23$603
Amlodipine Besylate73$549
ValacyclovirValacyclovir Hcl18$538
Prednisone140$521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$142$31,34823 claims
AbbVieSynthroid$213$2,60429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Summerfield

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →